SulkowskiMSMastEESeeffLBThomasDL. Hepatitis C virus infection as an opportunistic disease in persons infected with human immunodeficiency virus. Clin Infect Dis2000;30(suppl 1):S77–84.
2.
McHutchisonJGGordonSCSchiffERShiffmanMLLeeWMRustgiVKInterferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. N Engl J Med1998;339:1485–92.
3.
TraskPCEsperPRibaMRedmanB. Psychiatric side effects of interferon therapy: Prevalence, proposed mechanisms, and future directions. J Clin Oncol2000;18:2316–26.
MillerAMusselmanDPennaSSuCPearceBNemeroffC. Pretreatment with the antidepressant paroxetine prevents cytokine-induced depression during interferon-alpha therapy for malignant melanoma (abstract). Neuroimmunomodulation1999;6:237.
6.
ZajeckaJTracyKAMitchellS. Discontinuation symptoms after treatment with serotonin reuptake inhibitors. J Clin Psychiatry1997;58:291–7.
7.
BlochMStagerS VBraunARRubinowDR. Severe psychiatric symptoms associated with paroxetine withdrawal (letter). Lancet1995;346:57.
8.
Package insert. Virazole (ribavirin for inhalation solution). Costa Mesa, CA: ICN Pharmaceuticals, May 1996.
9.
NaranjoCABustoUSellersEMSandorPRuizIRobertsEAA method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther1981;30:239–45.
